Madison Reporter

Dr. Pierre Kory told an Arizona Senate committee that he left a previous position in the Midwest because his superiors disagreed with his treatment recommendations for COVID-19, which include ivermectin.

When the COVID-19 pandemic first started in 2020, Kory was chief of critical care and head of the main medical-surgical intensive care unit (ICU) at the University of Wisconsin.

“One of the reasons why I left is because I was getting blocked in my advocacy for treatment in the hospital with things like blood thinners and corticosteroids,” Kory said. “I was being overruled by my bosses, who thought what I was doing and proposing was most likely to cause harm.”

Kory was among the doctors who addressed the Novel Coronavirus Southwestern Intergovernmental Committee during a May 25 hearing in Phoenix. The two-day event, co-chaired by Arizona state Rep. Steve Montenegro (R-Goodyear) and state Sen. Janae Shamp (R-Surprise), was organized to investigate the state's response to the COVID-19 pandemic.

Now, Kory is president of the Front Line COVID-19 Critical Care (FLCCC) Alliance, a 501(c)3 that recommends treating COVID-19 infection with alternative modalities, such as ivermectin and hydroxychloroquine.

“Ivermectin is one of the cheapest medicines on earth with an unparalleled safety profile and is unmatched by almost any other FDA-approved drug,” Kory said. “That is a terrifying competitor to the pharmaceutical industry. You literally have a medicine that has almost no downside.”

In his talk, titled "The Global War on Ivermectin," the pulmonary and critical care specialist touted ivermectin as a miracle drug that can treat any age and any co-morbidity without almost any drug interactions.  

“Let us count the reasons why they wouldn't want you to use ivermectin or hydroxychloroquine early on to prevent hospitalizations and the bonanza of cash that they received by filling their hospitals with government bonuses,” Kory told the committee and the audience. “It's really because it threatened the Emergency Use Authorization (EUA).”

The Food and Drug Administration (FDA) issued EUAs for the COVID-19 vaccine, according to a White House statement online.

Kory further told the Committee that ivermectin wasn't promoted as a cure because it would have interfered with the rollout of the COVID-19 vaccine.

"It would increase vaccine hesitancy, and vaccine hesitancy was literally public enemy number one," he added. "So, if you are sitting here unvaccinated, you withstood the most global, terrifying misinformation and propaganda campaign ever conducted in history. So, congratulations." 

In December 2020, Kory also testified at the U.S. Senate Homeland Security Committee Meeting, "Focus on Early Treatment of COVID-19," where he accused authorities of only focusing on pharmaceutically engineered products such as remdesivir, monoclonal antibodies, and tocilizumab, which allegedly cost thousands of dollars.